乳腺钼靶X线摄影诊断早期乳腺癌的临床诊断价值

The Clinical Diagnostic Value of Mammography in the Diagnosis of Early Breast Cancer

摘要: 目的：探讨乳腺钼靶X线摄影诊断早期乳腺癌的临床诊断价值。方法：选取喀什地区第二人民医院2022年6月至2024年6月期间收治的150例疑似乳腺癌患者为研究对象，所有研究对象均实施彩色多普勒超声检查及乳腺钼靶X线摄影检查，并以病理检查结果作为检查的确定诊断标准，记录并比较两种检查方式对早期乳腺癌分型的诊断结果，准确度、灵敏度、特异度。结果：经过病理检查，本研究150例疑似乳腺癌患者中，有128例阳性、22例阴性；乳腺钼靶X线摄影诊断乳腺癌的灵敏度及准确度均高于彩色多普勒超声检查，两者之间有显著性差异，有统计学意义(P < 0.05)；而两种检查方式的特异度相比较，两者之间没有显著性差异，无统计学意义(P > 0.05)；两种检查方式对不同类型乳腺癌的检出率比较，差异均无统计学意义(P > 0.05)。结论：在早期乳腺癌的诊断及诊疗过程中，乳腺钼靶X线摄影检查与彩色多普勒超声检查相比，患者疾病诊断的准确度与灵敏度均有一定程度的提高，也能够为早期乳腺癌的诊断分型提供更可靠的临床诊断依据。

Abstract: Objective: To investigate the clinical diagnostic value of mammography in the diagnosis of early breast cancer. Methods: A total of 150 patients with suspected breast cancer admitted to the Second People’s Hospital of Kashgar from June 2022 to June 2024 were selected as the study subjects, and all the subjects were treated with color Doppler ultrasonography and mammography, and the pathological examination results were used as the “gold standard” to record and compare the accuracy, sensitivity and specificity of color Doppler ultrasound and mammography imaging methods, and to compare the diagnostic results of the two examination methods on the classification of early breast cancer. Results: After pathological examination, 128 of the 150 suspected breast cancer patients in this study were positive and 22 were negative. The sensitivity and accuracy of mammography in the diagnosis of breast cancer were higher than those of color Doppler ultrasonography, and the difference was statistically significant (P < 0.05), and the specificity of the two examination methods was not statistically significant (P > 0.05). There was no significant difference in the detection rate of different types of breast cancer between the two examination methods (P > 0.05). Conclusion: Compared with color Doppler ultrasonography, the use of mammography in the diagnosis of early breast cancer has improved the accuracy and sensitivity of diagnosis to a certain extent, which can provide a more reliable basis for the diagnosis and classification of early breast cancer.